DXR - Daxor Corporation
Daxor Corporation Logo

DXR - Daxor Corporation

https://www.daxor.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Daxor Corporation, a medical device company, provides cryobank and biotechnology services in the United States. The company is headquartered in New York, New York.

52W High
$11.48
52W Low
$6.55
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
-0.10
Valuation
Rich
As of 2024-12-31 (Overview)
Trailing P/E (<15 better)
69.12
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
N/A
EV/Revenue (<3 favorable)
16.73
P/S (TTM) (<3 favorable)
831.42
P/B (<3 favorable)
1.55
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
56.90%
Institutions (25–75% balanced)
2.02%
Shares Outstanding
4,984,400
Float
2,161,100
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
2018-01-05
Income & Growth
Profitability: Weak
As of 2024-12-31 (Overview)
Revenue (TTM)
66,310
Gross Profit (TTM)
66,310
EPS (TTM)
0.16
Profit Margin (>10% good)
27.11%
Operating Margin (TTM) (higher better)
-15.09%
ROE (TTM) (>15% strong)
0.05%
EPS YoY (Quarterly) (>10% good)
-0.36
Revenue YoY (Quarterly) (>8% good)
-0.74
Momentum
Bearish momentum
Value
0.3581
Previous
0.3254
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025